• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Respir Crit Care Med . Case Fatality Rates for COVID-19 Patients Requiring Invasive Mechanical Ventilation: A Meta-analysis

tetano

Editor, Senior Moderator
Am J Respir Crit Care Med


. 2020 Oct 29.
doi: 10.1164/rccm.202006-2405OC. Online ahead of print.
Case Fatality Rates for COVID-19 Patients Requiring Invasive Mechanical Ventilation: A Meta-analysis


Zheng Jie Lim[SUP] 1 [/SUP], Ashwin Subramaniam[SUP] 2 3 [/SUP], Mallikarjuna Ponnapa Reddy[SUP] 2 [/SUP], Gabriel Blecher[SUP] 4 5 [/SUP], Umesh Kadam[SUP] 6 7 8 [/SUP], Afsana Afroz[SUP] 9 10 [/SUP], Baki Billah[SUP] 9 [/SUP], Sushma Ashwin[SUP] 11 [/SUP], Mark Kubicki[SUP] 12 [/SUP], Federico Bilotta[SUP] 13 [/SUP], J Randall Curtis[SUP] 14 [/SUP], Francesca Rubulotta[SUP] 15 [/SUP]



Affiliations

Abstract

Rationale: Initial reports of case fatality rates (CFR) among adults with coronavirus diease-19 (COVID-19) receiving invasive medical ventilation (IMV) are highly variable.
Objective: To examine the CFR of patients with COVID-19 receiving IMV.
Methods: Two authors independently searched PubMed, Embase, medRxiv, bioRxiv, the COVID-19 living systematic review, and national registry databases. The primary outcome was the "reported CFR" for patients with confirmed COVID-19 requiring IMV. "Definitive hospital CFR" for patients with outcomes at hospital discharge was also investigated. Finally, CFR was analyzed by patient age, geographic region, and study quality based on the Newcastle-Ottawa Scale.
Results: Sixty-nine studies were included, describing 57,420 adult patients with COVID-19 who received IMV. Overall reported CFR was estimated as 45% (95% CI 39-52%). Fifty-four out of 69 studies stated whether hospital outcomes were available but provided a definitive hospital outcome on only 13,120 (22.8%) of the total IMV patient population. Among studies where age-stratified CFR was available, pooled CFR estimates ranged from 47.9% (95% CI 46.4-49.4%) in younger patients (age ≤40) to 84.4% (95% CI 83.3-85.4) in older patients (age >80). CFR was also higher in early COVID-19 epicenters. Overall heterogeneity is high (I2>90%) with non-significant Egger's regression test suggesting no publication bias.
Conclusion: Almost half of COVID-19 patients receiving IMV died, based on the reported CFR, but variable CFR reporting methods resulted in a wide range of CFR between studies. Reported CFR was higher in older patients and in early pandemic epicenters, which may be influenced by limited ICU resources. Reporting of definitive outcomes on all patients would facilitate comparisons between studies. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).
 
Back
Top Bottom